Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
501,599,603
-
Share change
-
-14,678,463
-
Total reported value
-
$7,589,043,254
-
Put/Call ratio
-
42%
-
Price per share
-
$15.13
-
Number of holders
-
333
-
Value change
-
-$163,013,515
-
Number of buys
-
181
-
Number of sells
-
152
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q3 2025
As of 30 Sep 2025,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
333 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
501,599,603 shares.
The largest 10 holders included
FMR LLC, MORGAN STANLEY, SB INVESTMENT ADVISERS (UK) LTD, BlackRock, Inc., VANGUARD GROUP INC, QVT Financial LP, VIKING GLOBAL INVESTORS LP, Rubric Capital Management LP, STATE STREET CORP, and Patient Square Capital LP.
This page lists
333
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.